Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
Outer Layers of the Cell Envelope01:18

Outer Layers of the Cell Envelope

The outermost layers of prokaryotic cells play a critical role in their survival, virulence, and interaction with the environment. These layers, often composed of polysaccharides, polypeptides, or proteins, form protective and adhesive structures that vary in organization and function.Capsules and Slime LayersCapsules are highly organized, tightly bound layers of polysaccharides that firmly attach to the bacterial cell wall. These structures serve as formidable protective barriers, preventing...
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

2.8K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ecological vaccination: A strategy to prevent zoonotic spillover from bats.

Science advances·2026
Same author

Preclinical development of a well-defined semisynthetic glycoconjugate vaccine against <i>Haemophilus influenzae</i> type b.

Science advances·2026
Same author

Synergistic phototherapy and Ca<sup>2+</sup> consumption for combating biofilms in diabetic wounds <i>via</i> ion interference, physical disruption, and biological regulation.

Bioactive materials·2025
Same author

C-reactive protein is a broad-spectrum capsule-binding receptor for hepatic capture of blood-borne bacteria.

The EMBO journal·2025
Same author

Development and Biological Properties of a New Live Attenuated Mumps Vaccine Strain.

Vaccines·2025
Same author

Macroporous hydrogel loaded with AIE-photosensitizer for enhanced antibacterial and wounds healing.

International journal of biological macromolecules·2025

Related Experiment Video

Updated: Jun 3, 2025

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

21.8K

Simplified process for preparing native and depolymerized capsular polysaccharides of Streptococcus pneumoniae.

Yuelong Li1, Hantian Yao2, Yanli Liu1

  • 1Beijing Minhai Biotechnology Co. Ltd, Beijing 102600, China.

Carbohydrate Polymers
|January 8, 2025
PubMed
Summary
This summary is machine-generated.

We developed a streamlined process for purifying Streptococcus pneumoniae capsular polysaccharides (CPSs) for vaccine production. This method simplifies impurity removal and size reduction, ensuring high-quality CPSs for effective pneumococcal vaccines.

Keywords:
Capsular polysaccharideImpurityInvasive pneumococcal diseaseNuclear magnetic resonancePolysaccharide depolymerizationPolysaccharide purificationPolysaccharide vaccineStreptococcus pneumoniae

More Related Videos

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

4.9K
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

45.6K

Related Experiment Videos

Last Updated: Jun 3, 2025

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
09:11

Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination

Published on: September 25, 2014

21.8K
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

4.9K
Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction
04:25

Capsular Serotyping of Streptococcus pneumoniae Using the Quellung Reaction

Published on: February 24, 2014

45.6K

Area of Science:

  • Microbiology
  • Vaccine Development
  • Biochemistry

Background:

  • Streptococcus pneumoniae causes severe infections like pneumonia and meningitis.
  • Bacterial capsular polysaccharides (CPSs) are key virulence factors and vaccine targets.
  • Current vaccine production requires highly purified native and depolymerized CPSs.

Purpose of the Study:

  • To streamline and optimize the purification process for Streptococcus pneumoniae capsular polysaccharides (CPSs).
  • To develop a more efficient method for obtaining both native and depolymerized CPSs for vaccine manufacturing.
  • To ensure the purity and structural integrity of CPSs meet stringent pharmacopeial standards.

Main Methods:

  • Implemented a streamlined purification protocol involving ultrafiltration, one-step acid precipitation, and diafiltration for native CPSs.
  • Integrated trifluoroacetic acid (TFA) hydrolysis for efficient depolymerization of CPSs.
  • Assessed purity and structural integrity against traditional methods and European Pharmacopeia standards.

Main Results:

  • The optimized process successfully yielded purified native and depolymerized CPSs.
  • The purity and structural integrity of the produced CPSs were comparable to those obtained via traditional, multi-step methods.
  • The streamlined process simplifies CPS purification for pneumococcal vaccine production.

Conclusions:

  • The developed method offers an efficient and effective approach to CPS purification for pneumococcal vaccines.
  • This optimized process meets the rigorous quality standards required for vaccine manufacturing.
  • Streamlined CPS purification is crucial for the consistent and scalable production of pneumococcal vaccines.